AlbertoS.PappoMD

PubMed

• 26 citations
  ACCELERATE - Five years accelerating cancer drug development for children and adolescents.
  Andrew D J Pearson, Susan L Weiner, Peter C Adamson, Dominik Karres, Gregory Reaman
  European Journal of Cancer. 2022-05-01
• 83 citations
  Infantile Fibrosarcoma With NTRK3-ETV6 Fusion Successfully Treated With the Tropomyosin-Related Kinase Inhibitor LOXO-101.
  Ramamoorthy Nagasubramanian, Julie Wei, Paul Gordon, Jeffrey C. Rastatter, Michael C. Cox
  Pediatric Blood & Cancer. 2016-08-01
• 33 citations
  XAF1 as a modifier of p53 function and cancer susceptibility
  Emilia M. Pinto, Bonald C. Figueiredo, Wenan Chen, Henrique de Campos Reis Galvão, Maria Nirvana Formiga
  Science Advances. 2020-06-01

Journal Articles

• Association of Hearing Impairment with Neurocognition in Survivors of Childhood Cancer  
  Daniel A Mulrooney, Amar Gajjar, Alberto S Pappo, JAMA Oncology
• Clinical Genome Sequencing Uncovers Potentially Targetable Truncations and Fusions of MAP3K8 in Spitzoid and Other Melanomas  
  Alberto Pappo, Armita Bahrami, Elizabeth M Azzato, Kim E Nichols, David W Ellison, Nature
• Article Identification of Therapeutic Targets in Rhabdomyosarcoma Through Integrated Genomic, Epigenomic, and Proteomic Analyses  
  Armita Bahrami, Alberto Pappo, ScienceDirect
• Long-term functional outcomes and quality of life in adult survivors of childhood extremity sarcomas: a report from the St Jude Lifetime Cohort Study  
  Fernandez-Pineda I, Hudson MM, Pappo AS, Bishop MW, Klosky JL, Brinkman TM, Srivastava DK, Neel MD, Rao BN, Davidoff AM, Krull KR, Mulrooney DA, Robison LL, Ness KK, J Cancer Surviv, 1/1/2017
• Long-term outcomes of pediatric and adolescent mediastinal germ cell tumors: a single pediatric oncology institutional experience  
  Grabski DF, Pappo AS, Krasin MJ, Davidoff AM, Rao BN, Fernandez-Pineda I, Pediatr Surg Int, 1/1/2017
• Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with increased risk of recurrence: A report from the Soft Tissue ...  
  Walterhouse DO, Pappo AS, Meza JL, Breneman JV, Hayes-Jordan A, Parham DM, Cripe TP, Anderson JR, Meyer WH, Hawkins DS, Cancer, 1/1/2017
•  
  Agarwala SS, Lee SJ, Yip W, Rao UN, Tarhini AA, Cohen GI, Reintgen DS, Evans TL, Brell JM, Albertini MR, Atkins MB, Dakhil SR, Conry RM, Sosman JA, Flaherty LE, Sondak..., J Clin Oncol, 1/1/2017
• Genetic and Epigenetic Alterations of TERT Are Associated with Inferior Outcome in Adolescent and Young Adult Patients with Melanoma  
  Seynnaeve B, Lee S, Borah S, Park Y, Pappo A, Kirkwood JM, Bahrami A, Sci Rep, 1/1/2017
• Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group  
  Rudzinski ER, Anderson JR, Chi YY, Gastier-Foster JM, Astbury C, Barr FG, Skapek SX, Hawkins DS, Weigel BJ, Pappo A, Meyer WH, Arnold MA, Teot LA, Parham DM, Pediatr Blood Cancer, 1/1/2017
• Telomerase Expression by Aberrant Methylation of the TERT Promoter in Melanoma Arising in Giant Congenital Nevi  
  Fan Y, Lee S, Wu G, Easton J, Yergeau D, Dummer R, Vogel P, Kirkwood JM, Barnhill RL, Pappo A, Bahrami A, J Invest Dermatol, 1/1/2016
• Redefining “rare” cancers  
  Pui CH, Pappo A, Gajjar A, Downing JR, Lancet Oncology, 1/1/2016
• The landscape of fusion transcripts in spitzoid melanoma and biologically indeterminate spitzoid tumors by RNA sequencing  
  Wu G, Barnhill RL, Lee S, Li Y, Shao Y, Easton J, Dalton J, Zhang J, Pappo A, Bahrami A, Mod Pathol, 1/1/2016
• Association of TERT promoter mutations with telomerase expression in melanoma  
  Lee S, Opresko P, Pappo A, Kirkwood JM, Bahrami A, Pigment Cell Melanoma Res, 1/1/2016
• Molecular subtypes of KIT/PDGFR wild-type gastrointestinal stromal tumors A report from the National Institutes of Health Gastrointestinal Stroma Tumor Clinic  
  Sosipatros B, Pappo AS, Killian K, LaQuaglia MP, Weldon C, George S, Trent JC, vonMeheren M, Wright JA, Schiffman JD, Raygada M, Pacak K, Meltzer PS, Miettinen MM, Str..., JAMA Oncol, 1/1/2016
• Feasibility of Pegylated Interferon in Children and Young Adults with Resected Stage III Melanoma  
  Navid F, Herzog C, Sandoval J, Daryani V, Stewart C, Gattuso J, Mandrell B, Phipps S, Chemaitilly W, Davidoff A, Shulkin B, Jenkins J, Mao S, Wu J, Schiff D, Rao B, P..., Pediatr Blood Cancer, 1/1/2016
• Comparison of 18 F-FDG-PET-CT and bone scintigraphy for evaluation of osseous metastases in newly diagnosed and recurrent osteosarcoma  
  Hurley C, McCarville MB, Shulkin BL, Mao S, Wu J, Navid F, Daw NC, Pappo AS, Bishop MW, Pediatr Blood Cancer, 1/1/2016
• Infantile Fibrosarcoma With NTRK3-ETV6 Fusion Successfully Treated With the Tropomyosin-Related Kinase Inhibitor LOXO-101  
  Nagasubramanian R, Wei J, Gordon P, Rastatter JC, Cox MC, Pappo A, Pediatr Blood Cancer, 1/1/2016
• Prognostic Significance of Major Histocompatibility Complex Class II Expression in Pediatric Adrenocortical Tumors: A St Jude and Children's Oncology Group Study  
  Pinto E, Rodriguez-Galindo C, Choi J, Pounds S, Liu Z, Neale G, Finkelstein D, Hicks J, Pappo A, Figueiredo B, Ribeiro R, Zambetti G, Clin Cancer Res, 1/1/2016
• Soft Tissue Sarcoma, Version 22016, NCCN Clinical Practice Guidelines in Oncology  
  von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Conrad EU 3rd, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM 3rd, Koon H, Mayerson J, McCarter M, McGarr..., J Natl Compr Canc Netw, 1/1/2016
• Awareness of intramuscular capillary type hemangioma in the differential diagnosis of soft-tissue tumors in children  
  Fernandez-Pineda I, Jenkins JJ, Santiago TC, Prajapati HJ, Pappo AS, Pediatr Blood Cancer, 1/1/2016
• Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic  
  Weldon CB, Madenci AL, Janeway KA, George S, von Mehren M, Pappo AS, Schiffman JD, Wright J, Trent JC, Pacak K, Stratakis CA, Helman LJ, La Quaglia MP, J Clin Oncol, 1/1/2016
• The role of computed tomography (CT) as a surveillance tool in children with high-risk neuroblastoma  
  Federico SM, Brady SL, Pappo AS, Wu J, Mao S, McPherson VJ, Young A, Furman WL, Kaufman R, Kaste S, Pediatr Blood and Cancer, 1/1/2015
• Genomic landscape of paediatric adrenocortical carcinoma  
  Pinto EM, Chen X, Easton J, Finkelstein D, Liu Z, Pounds S, Rodriguez-Galindo C, Lund TC, Mardis ER, Wilson RK, Boggs K, Yergeau D, Cheng J, Mulder HL, Manne J, Jenkin..., Nat Commun, 1/1/2015
• TERT Promoter Mutations Predict Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms  
  Bahrami A, Barnhill R, Dummer R, Lee S, Dalton J, Wu J, Pappo A, Scientific reports, 1/1/2015
• Germline ETV6 mutations confer susceptibility to acute lymphoblastic leukemia and thrombocytopenia  
  Topka S, Vijai J, Walsh MF , Jacobs L, Maria A, Villano D, Gaddam P, Wu G, McGee RB, Quinn E, Inaba H, Hartford C, Pui CH, Pappo AS, Edmonson M, Zhang M, Stepensky P, ..., PLoS Genetics, 1/1/2015
• Join now to see all

Books/Book Chapters

• Cancer: Principals and Practice of Oncology 
  Chapter: Solid Tumors of Childhood 
  Page 1465 - 1499Pappo AS, Navid F, Brennan R, Krasin M, Davidoff A, Furman WEditors: De Vitta V, Lawrence T, Rosenberg S.Wolters Kluwer, PAEdition 10th,2015
• Textbook of uncommon cancers 
  Chapter: Malignant tumors of the skin and subcutaneous tissue in children 
  Page 943 - 957Pappo AS, Rodriguez-Galindo CEditors: Raghavan D, Blanke CD, et al.Wiley Blackwell, NJEdition 4th,2012
• Textbook of uncommon cancers 
  Chapter: Uncommon tumors of the gastrointestinal tract 
  Page 851 - 866Pappo AS, Furman WLEditors: Raghavan D, Blanke CD, et al.Wiley Blackwell, NJEdition 4th,2012
• Textbook of uncommon cancers 
  Chapter: Introduction to rare cancers in childhood 
  Page 847 - 850Pappo AS, Reaman GHEditors: Raghavan D, Blanke CD, et al.Wiley Blackwell, NJEdition 4th,2012
• A Rare tumors in children and adolescents 
  Chapter: Rare Tumors of the skin and subcutaneous tissue 
  Page 431 - 454Pappo AS, Eigentler TK, Garbe C, Collini P, Ferrari A, Rossler JEditors: Schneider DT, Brecht IB, Olson TA, Ferrari A.Springer, Berlin, Germany2012
• Principles and practice of pediatric oncology 
  Chapter: The nonrhabdomyosarcoma soft tissue sarcomas 
  Page 954 - 986Ocku MF, Pappo AS, Hicks J, Million L, Andrassy RJ, Spunt SLEditors: Pizzo PA, Poplack DG.Lippincott Williams and Wilkins, Philadelphia, PAEdition 6th,2011
• Oncology of infancy and childhood 
  Chapter: Rare tumors of childhood 
  Page 989 - 1013Albritton K, Goldberg JM, Pappo AEditors: Orkin SH, Fisher DE, Look AT, Lux SE, Ginsburg D, Nathan DG.Saunders Elsevier, Philadelphia, PA2009
• Cancer principles and practice of oncology 
  Chapter: Solid tumors of childhood 
  Page 2043 - 2083Russell HV, Pappo AS, Nuchtern JG, Kornguth DG, Wang LLEditors: DeVita VT Jr, Lawrence TS, Rosenberg SA.Lippincott Williams and Wilkins, Philadelphia, PA2008
• Cancer in adolescents and young adults 
  Chapter: Malignant melanoma 
  Page 271 - 291Herzog CE, Bleyer WA, Pappo ASEditors: Bleyer W, Barr RD.Springer-Verlag, Berlin & Heidelberg, Germany2007
• Principles and practice of pediatric oncology 
  Chapter: Nonrhabdomyosarcomatous soft tissue sarcomas 
  Page 1031 - 1073Ocku MF, Merchant TE, Pappo AS, Hicks J, Andrassy RJ, Horowitz MEEditors: Pizzo PA and Poplack DG.Lippincott Williams and Wilkins, Philadelphia, PAEdition 5th,2006
• Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival 
  Chapter: Malignant Melanoma 
  Herzog C, Pappo A, Bondy M, Bleyer A, Kirkwood JMEditors: Bleyer WA, O’Leary M, Barr F, Ries LAG, Andreson B, Valle CG.Bethesda, MD2006
• Pediatric bone and soft Tissue sarcomas 
  Chapter: Pediatric Rhabdomyosarcoma: Biology and Results of the North American Intergroup Rhabdomyosarcoma Trials 
  Page 103 - 132Pappo AS, Barr F, Wolden SEditors: Pappo AS.Springer, Berlin, Germany2005
• Pediatric Bone and Soft Tissue Sarcomas 
  Page 1 - 240Editors: Pappo AS.Springer, Berlin, Germany2005
• Cancer Medicine 
  Chapter: Less frequently encountered tumors of childhood 
  Page 2349 - 2356Rodriguez-Galindo C, Pappo ASEditors: Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Gansler TS, Holland JF, Frei W.BC Decker, Inc., Hamilton, ON, Canada2003
• Principles and practice of pediatric oncology 
  Chapter: Other soft tissue sarcomas of childhood 
  Page 1017 - 1050Miser JS, Pappo AS, Triche TJ, Merchant TE, Rao BNEditors: Pizzo PA and Poplack DG..Lippincott Williams and Wilkins, Philadelphia, PA2002
• Principles and practice of pediatric oncology 
  Chapter: Management of infrequent cancers of childhood 
  Page 1149 - 1175Pratt CB, Pappo ASEditors: Pizzo PA and Poplack DG.Lippincott Williams and Wilkins, Philadelphia, PA2002
• Childhood Cancer. A handbook from St. Jude Children’s Research Hospital 
  Chapter: Rhabdomyosarcoma 
  Page 425 - 431Pappo A, Pring KEditors: Steen G PhD and Mirro J, M.D..Perseus Publishing, Cambridge, MA2000
• Childhood Cancer. A handbook from St. Jude Children’s Research Hospital 
  Chapter: The Ewing’s sarcoma family of tumors 
  Page 383 - 389Pappo A, Pring KEditors: Steen G PhD and Mirro J, M.D..Perseus Publishing, Cambridge, MA2000
• Advances in Head and Neck Oncology 
  Chapter: Rhabdomyosarcoma of the head and neck in children 
  Page 119 - 132Pappo AS, Crist WMEditors: Robbins KT.Singular publishing, San Diego, CA1998
• Diagnostic and Therapeutic Advances in Pediatric Oncology 
  Chapter: Rhabdomyosarcoma: Biology and Therapy 
  Page 309 - 339Pappo AS, Shapiro DNEditors: Walterhouse DO and Cohn SL.Kluwer Academic Publishers1997
• Cutaneous melanoma 
  Chapter: Childhood melanoma 
  Page 175 - 186Pappo AS, Kaste SC, Rao BN, Pratt CBEditors: Balch CM, Houghton AN, Sober AJ,, Soong SJ.Quality Medical Publishing, St. Louis, MO1997
• Soft Tissue Sarcomas: Present achievements and future prospects 
  Chapter: Soft tissue sarcomas in children 
  Page 205 - 222Pappo AS, Pratt CBEditors: Verweij J, Pinedo HM, Suit HD.Kluwer Academic Publishers, Boston, MA1997
• Nelson Textbook of Pediatrics 
  Chapter: Other soft tissue sarcomas and benign tumors 
  Pappo ASEditors: Behrman RE, Kliegman RM, Arvin AM.WB Saunders1996
• Clinical Oncology 
  Chapter: Pediatric Tumors 
  Page 1847 - 1887Pappo AS, Kuttesch JF, Santana VM, Shapiro DNEditors: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE.Churchill Livingston1995
• Natahan and Oski’s Hematology and Oncology of Infancy and Childhood. 8th edition 
  Chapter: Rare tumors of childhood 
  Page 2123 - 2145Goldberg JM, Pappo AS, Bishop MEditors: Orkin SH, Fisher DE, Ginsburg D. Look AT, Lux SE, Nathan DG.Elsevier, Philadelphia, PAEdition 8th,
• Join now to see all

Abstracts/Posters

• Ewing sarcoma: Is there a role for high dose chemotherapy?
  Pappo A, ASCO (American Society of Clinical Oncology) Annual Conference, Chicago, IL, 1/1/2016
• A pediatric phase 1 study of LOXO-101, a highly selective inhibitor of the tropomyosin receptor kinase (TRK) family
  Nagasubramanian R, DuBois SG, Laetsch TW, Mascarenhas L, Smith S, Reynolds M, Cruickshank S, Donahue L, Pappo AS, Cox MC, J Clin Oncol, 1/1/2016
• Improved clinical responses with the concomitant use of an anti-GD2 monoclonal antibody and chemotherapy in newly diagnosed children with high-risk (HR) neuroblastoma ...
  Furman WL, Federico SM, McCarville MB, Davidoff AM, Krasin MJ, Wu J, Brennan RC, Bishop MW, Santana VM, Bahrami A, Anthony G, Gillies SD, Sondel PM, Leung WH, Pappo AS, J Clin Oncol, 1/1/2016
• Treatment of Childhood Nasopharyngeal Carcinoma (cNPC) with neoadjuvant chemotherapy (NAC) and concomitant chemoradiotherapy (CCRT): Results of the Children’s Oncology...
  Rodriguez-Galindo C, Krailo MD, Krasin MJ, McCarville MB, Hicks J, Pashankar F, Pappo AS, J Clin Oncol, 1/1/2016
• TERT promoter mutations and telomerase expression in melanoma in adolescents and young adults
  Seynnaeve B, Lee S, Park Y, Pappo AS, Kirkwood JM, Bahrami A, J Clin Oncol, 1/1/2016
• Phase I expansion cohort to evaluate bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory or recurrent solid tumors
  Federico SM, McCarville MB, Stewart CF, Mao S, Wu J, Davidoff AM, Furman WL, Santana VM, Pappo AS, Navid F, J Clin Oncol, 1/1/2016
• Association of age at diagnosis and stage of disease with ATRX mutations in neuroblastoma
  Federico SM, Chen X, Easton J, Wu J, Mao S, Liu Y, Naranjo A, Pappo AS, Hogarty MD, Dyer MA, J Clin Oncol, 1/1/2016
• Treatment of Childhood Adrenocortical Carcinoma (ACC) with surgery plus retroperitoneal lymph node dissection (RPLND) and multiagent chemotherapy: Results of the Child...
  Rodriguez-Galindo C, Pappo AS, Krailo MD, Pashankar F, Caran EM, Hicks J, McCarville MB, Weldon CB, Malkin D, Zambetti G, de Oliveira-Filho AC, LaQuaglia MP, Mastellar..., J Clin Oncol, 1/1/2016
• Phase 1/2 study of pembrolizumab (pembro) in children with advanced melanoma or a PD-L1–positive (PD-L1+) advanced, relapsed, or refractory solid tumor or lymphoma (KE...
  Geoerger B, Fox E, Pappo AS, Oren MY, Marshall LV, Heath K, Diede SJ, Ebbinghaus S, Park JR; Roussy G, France V, J Clin Oncol, 1/1/2016
• Results of Completion Lymph Node Dissection (CLND) in Sentinel Lymph Node-positive Pediatric Melanoma: A Single Institution Experience
  Wahid FN, Loh A, Navid F, Pappo A, Bahrami A, McCarville MB, Shulkin B, Wu J, Sandoval JA, Davidoff, AM, Rao B, International College of Surgeons Meeting, Memphis, TN, 1/1/2014
• Phase III trial of high-dose interferon alpha-2b versus cisplatin, vinblastine, DTIC plus IL-2 and interferon in patients with high-risk melanoma (SWOG S0008): An inte...
  Flaherty LE, Moon J, Atkins MB, Tuthill R, Thompson JA, Vetto JT, Haluska FG, Pappo AS, Sosman JA, Redman BG, Ribas A, Kirkwood JM, Sondak VK, J Clin Oncol, 1/1/2012
• Vincristine(V), dactinomycin (A), and lower doses of cyclophosphamide (C) with or without radiation therapy for patients with newly diagnosed low-risk embryonal Rhabdo...
  Walterhouse D, Pappo AS, Meza JL, Breneman JC, Hayes-Jordan AA, Parham D, Cripe TP, Meyer WH, Hawkins DS, J Clin Oncol, 1/1/2012
• Adolescent and young adult oncology
  Coccia PF, Altman J, Bhatia S, Borinstein SC, Flynn J, George S, Goldsby R, Hayashi R, Huang MS, Johnson RH, Beaupin LK, Link MP, Oeffinger KC, Orr KM, Pappo AS, Reed ..., J Natl Compr Canc Netw, 1/1/2012
• Special considerations in pediatric gastrointestinal tumors
  Pappo AS, Janeway K, Laquaglia M, Kim SY, J. Surg. Oncol., 1/1/2011
• Activity of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF1R), in patients with recurrent or refractory Ewing’s sarcoma family of tumor...
  Pappo AS, Patel S, Crowley J, Reinke DK, Staddon AP, Kuenkele K, Chawla SP, Benjamin RS, Helman LJ, Baker LH, J Clin Oncol, 1/1/2010
• The Rare Tumor Initiative of the Children’s Oncology Group: Lessons Learned in the First 6 Years and Their Effect on Future Plans
  Pappo A, Krailo M, Chen Z, Reaman G, ASCO, 1/1/2009
• Preliminary results from a phase II study of ARQ 197 in patients with microphthalmia transcription factor family (MiT)-associated tumors
  Goldberg J, Demetri GD, Choy E, Rosen L, Pappo A, Dubois S, Geller J, Chai F, Ferrari D, Wagner AJ, J Clin Oncol, 1/1/2009
• A SARC global collaborative phase II trial of R1507, a recombinant human monoclonal antibody to the insulin-like growth factor-1 receptor (IGF1R) in patients with recu...
  Patel S, Pappo A, Crowley J, Reinke D, Eld, J, Ritland S, Chawla S, Staddon A, Maki R, Vassal G, Helman L, J Clin Oncol, 1/1/2009
• Incidence of pediatric melanoma in Texas: A report from the Texas Cancer Registry, 1995-2003
  Pappo AS, Lyden E, Breitfeld LP, Donaldson SS, Anderson J, Qualman S, Wiener E, Crews K, Houghton P, Meyer W. Vincristine (V) and Irinotecan (CPT): A highly active com..., ASCO, 1/1/2007
• Phase 2 Trial of imatinib mesylate (IM) for treatment of recurrent or refractory pediatric solid tumors: A Children’s Oncology Group study
  Bondy M, Bernstein ML, Pappo A, Schultz KR, Krailo M, Fouladi M, Hill DA, Heinrich M, Blaney S, Adamson PC, B.C., ASCO, 1/1/2005
• Clinical and molecular characteristics of pediatric gastrointestinal stromal tumors (GISTs)
  Price V, Zielenska M, Smith C, Shilton-Macneill S, Malkin D, Pappo A, ASCO, 1/1/2004
• Malignant melanoma in the first three decades of life: A report from the U.S. Surveillance, Epidemiology and End Results (SEER) Program
  Pappo A, Ries L, Herzog C, Bleyer A, ASCO, 1/1/2004
• Irinotecan (CPT-11) is active against pediatric rhabdomyosarcoma (RMS): A Phase II window trial from the Soft Tissue Sarcoma Committee (STS) of the Children’s Oncology...
  Pappo A, Lyden E, Breitfeld P, Houghton P, Parham D, Donaldson S, Meyer W, and Crist W, ASCO, 1/1/2002
• A Retrospective Review of Patients With Metastatic Rhabdomyosarcoma (RMS) Treated At The Hospital For Sick Children (HSC) Between 1989-1999
  Williams BA, Williams K, Doyle J, Greenberg M, Pappo AS, Malkin D, ASPHO, 1/1/2002
• Synovial sarcoma of childhood and adolescence: multicenter multivariate analysis of outcome of 220 patients
  Okcu MF, Treuner J, Mattke A, Pappo A, Ferrari A, Munsell M, Ozkan A, Casanova M, Raney B, ASCO, 1/1/2002
• Join now to see all

Lectures

• Melanoma in Children and Adolescents: A multidisciplinary Workshop and Case Discussion on Diagnosis Therapy and Follow-up 
  Minneapolis, MN - 1/1/2016
• Rare Cancers in Children 
  Children’s Mercy Hospital, Kansas City, MO - 1/1/2016
• NCI Pediatrics Provocative Questions Workshop 
  St. Jude Children’s Research Hospital, Memphis, TN - 1/1/2015
• Pediatric Cancer Genome Project 
  Charlotte, NC - 1/1/2015
• Pediatric Solid Tumors: Challenges and Opportunities 
  Cook Children’s Hospital, Fort Worth, TX - 1/1/2015
• What Rare Childhood Cancers Can Teach Us? 
  Rainbow Babies & Children’s Hospital, Cleveland, OH - 1/1/2015
• Rare Tumors: Improving Outcomes in the Modern Era 
  Chicago, IL - 1/1/2015
• Promesa Presentation 
  St. Jude Children’s Research Hospital, Memphis, TN - 1/1/2014
• Osteosarcoma 
  St. Jude Children’s Research Hospital, Memphis, TN - 1/1/2014
• Developmental Biology and Solid Tumor Program (DBSTP) Speaker, “REBX: A Protocol for Prospectively Collecting and Banking Fresh Tumor Tissue in Children and Adolescent... 
  St. Jude Children’s Research Hospital, Memphis, TN - 1/1/2014
• The BRAF pathway: An emerging therapeutic target in Childhood Cancer 
  1/1/2014
• Osteosarcoma: Biology and Therapy 
  New York, NY - 1/1/2013
• Rare Cancer in Children: An Overview 
  St. Jude Children’s Research Hospital, Memphis, TN - 1/1/2013
• Pediatric and SDH deficient Gist: An up and coming disease 
  Bethesda, MD - 1/1/2013
• Genetic Profiles of Pediatric Cutaneous Melanoma 
  St. Jude Children’s Research Hospital, Memphis, TN - 1/1/2013
• DPLM Symposium 
  Toronto, Ontario, Canada - 1/1/2013
• Treating Rare Cancer in Children 
  St. Jude Children’s Research Hospital, Memphis, TN - 1/1/2012
• Rare Cancers in Children: Opportunities and Challenges 
  Seattle, WA - 1/1/2012
• Treating rare cancers in children: The importance of evidence 
  Chicago, IL - 1/1/2012
• New drugs for pediatric sarcomas: The rise and fall of three promising agents. Development Therapeutics for Solid Malignancies (DTSM) 
  St. Jude Children’s Research Hospital, Memphis, TN - 1/1/2012
• The Challenge of Rare Cancers in Children 
  UT Southwestern Medical Center, Dallas, TX - 1/1/2012
• Melanoma as a subsequent neoplasm in cancer survivors 
  Chicago, IL - 1/1/2011
• Solid Tumor Program Clinical Update. Development Therapeutics for Solid Malignancies (DTSM) 
  St. Jude Children’s Research Hospital, Memphis, TN - 1/1/2011
• Clinical Practice Guidelines & Quality Cancer Care 
  Hollywood, FL - 1/1/2011
• Research opportunities in Rare Childhood Cancers: Melanoma and GIST as Potential Models 
  Memphis, TN - 1/1/2011
• Join now to see all

Other

• Sacrococcygeal germ cell tumors 
  Pappo AS, Egler RA
  http://www.uptodate.com/contents/sacrococcygeal-germ-cell-tumors
  UpToDate, Wolters Kluwer Health - 2012-04-02